8 Oral: ALTA3263: an oral, KRAS isoform-selective, dual ON/OFF state, noncovalent inhibitor induces regressions across KRAS G12V, G12D, and G12C cancer models von Wang, T., Ibanez, M., Yu, K., Fan, K., Juan, J., Perez, M., Smith, T., Walsh, B., Kang, V., Tyhonas, J., Alvarez, N., Tran, J., Moorefield, K.S., Phimister, A., Zhu, X., Chi, A., Bartberger, M.D., Murphy, E.

Volltext